Position in ZTS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$236,774
+$7,279 QoQ
Shares Held
2,003
+9.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Martin Capital Advisors, LLP holds $1,582,891 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
14,268 | $1,582,891 |
All Filings in ZTS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $236,774 | 2,003 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $229,495 | 1,824 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $238,355 | 1,629 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $246,556 | 1,581 | Shares | Sole | 2025-07-15 | |
| 2024-09-30 | $240,512 | 1,231 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $213,406 | 1,231 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $208,297 | 1,231 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $276,515 | 1,401 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $255,402 | 1,468 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $248,843 | 1,445 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $218,535 | 1,313 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $213,376 | 1,456 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $215,910 | 1,456 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $250,271 | 1,456 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $265,157 | 1,406 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $330,904 | 1,356 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||